We are live on ! Find out more
Verition Fund Management

Verition Fund Management Portfolio holdings

AUM $15.4B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
Cap. Flow
-$307M
Cap. Flow %
-4.25%
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679

Sector Composition

Rank Sector Weight
1 Financials 12.25%
2 Industrials 9.66%
3 Utilities 9.48%
4 Technology 8.06%
5 Healthcare 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNA icon
1876
Ginkgo Bioworks
DNA
$614M
$23.1K ﹤0.01%
435
-692
-61% -$43.9K
KRON
1877
DELISTED
Kronos Bio
KRON
$22.9K ﹤0.01%
+15,700
New +$30.1K
APCXW
1878
DELISTED
AppTech Payments Corp Warrant
APCXW
$22.1K ﹤0.01%
70,000
BLEUR
1879
DELISTED
bleuacacia ltd Rights
BLEUR
$22K ﹤0.01%
563,750
ADCT icon
1880
ADC Therapeutics
ADCT
$140M
$21.9K ﹤0.01%
+11,241
New +$41.5K
RCFA.WS
1881
DELISTED
RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RCFA.WS
$21.7K ﹤0.01%
227,900
TENX icon
1882
Tenax Therapeutics
TENX
$504M
$20.3K ﹤0.01%
+545
New +$56.8K
APXIW
1883
DELISTED
APx Acquisition Corp. I Warrant
APXIW
$20.1K ﹤0.01%
240,828
SCOR icon
1884
Comscore
SCOR
$115M
$19.7K ﹤0.01%
+800
New +$19.5K
AFMD
1885
DELISTED
Affimed
AFMD
$19K ﹤0.01%
+2,547
New +$25.5K
EFHTR
1886
DELISTED
EF Hutton Acquisition Corporation I Rights
EFHTR
$18.9K ﹤0.01%
142,467
-2,221
-2% -$362
NFNT.WS
1887
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
$18.8K ﹤0.01%
104,644
SVIIW
1888
DELISTED
Spring Valley Acquisition Corp II Warrant
SVIIW
$18.4K ﹤0.01%
96,898
-500
-0.5% -$118
VCXB.WS
1889
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
$18.4K ﹤0.01%
217,139
ECXWW
1890
ECARX Holdings Warrants
ECXWW
$1.24M
$18.3K ﹤0.01%
122,250
ASBPW
1891
Aspire Biopharma Warrant
ASBPW
$447K
$18.1K ﹤0.01%
432,757
GFGDW
1892
DELISTED
The Growth for Good Acquisition Corporation Warrant
GFGDW
$17.9K ﹤0.01%
187,450
MVSTW
1893
DELISTED
Microvast Holdings Warrants
MVSTW
$17.8K ﹤0.01%
85,900
ICNC.WS
1894
DELISTED
Iconic Sports Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ICNC.WS
$16.8K ﹤0.01%
112,473
BTMWW
1895
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$16.4K ﹤0.01%
394,700
-230,300
-37% -$22.7K
GTACW
1896
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$15.9K ﹤0.01%
173,470
ABPWW
1897
DELISTED
Abpro Holdings Warrant
ABPWW
$15.7K ﹤0.01%
225,000
CBRGW
1898
DELISTED
Chain Bridge I Warrants
CBRGW
$15.1K ﹤0.01%
201,925
FAASW
1899
DELISTED
DigiAsia Corp Warrant
FAASW
$15K ﹤0.01%
162,850
-40,000
-20% -$3.08K
CMCAW
1900
DELISTED
Capitalworks Emerging Markets Acquisition Corp Warrant
CMCAW
$15K ﹤0.01%
181,200

Similar funds

Verition Fund Management's Q1 2023 Portfolio in Review

As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.

Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.

  • Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
  • Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
  • Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
  • Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
  • Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
  • Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
  • Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.

Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.